In order to strengthen the management of the appointment and evaluation of drug GMP inspectors, standardize GMP inspection and certification, advance the implementation of Good Manufacturing Practice for Pharmaceutical Products (2010 revised edition), the State Food and Drug Administration (SFDA) organized the development of the Interim Requirements for the Appointment and Evaluation of Drug GMP Inspectors and issued the Interim Requirements recently. The Interim Requirements goes into effect from the date of promulgation.